NEUROENDOCRINE NEOPLASM
Clinical trials for NEUROENDOCRINE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE NEOPLASM trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double-Team strategy tested for Tough-to-Treat cancer
Disease control OngoingThis study is testing if combining an immunotherapy drug (pembrolizumab) with a targeted radiation treatment or a procedure to treat liver tumors works better for people with advanced neuroendocrine tumors. The goal is to see if this two-part approach helps the immune system figh…
Matched conditions: NEUROENDOCRINE NEOPLASM
Phase: PHASE2 • Sponsor: Nicholas Fidelman, MD • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for slowing advanced neuroendocrine tumors in major trial
Disease control OngoingThis study is testing if a drug called cabozantinib can slow the growth of advanced neuroendocrine tumors better than a placebo (inactive pill). It is for about 298 patients whose cancer has continued to grow despite receiving at least one prior standard treatment. The main goal …
Matched conditions: NEUROENDOCRINE NEOPLASM
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Major cancer trial tests new drug duos for rare, aggressive tumors
Disease control OngoingThis large Phase 3 trial aims to find the better treatment combination for patients with advanced, high-risk neuroendocrine tumors (like carcinoid tumors) that have spread. Researchers are comparing a standard drug (octreotide) paired with either interferon or bevacizumab to see …
Matched conditions: NEUROENDOCRINE NEOPLASM
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New drug combo tested to halt rare, spreading tumors
Disease control OngoingThis study is testing whether two oral medications, lenvatinib and everolimus, can help control advanced carcinoid tumors that have spread and cannot be surgically removed. The trial aims to see if the drug combination can shrink tumors or stop their growth, and to monitor side e…
Matched conditions: NEUROENDOCRINE NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Scientists test Two-Pronged attack on rare digestive cancers
Disease control OngoingThis early-stage trial is testing whether adding an experimental pill called peposertib to a targeted radiation treatment (lutetium Lu 177 dotatate) is safe and effective for patients with advanced neuroendocrine tumors in the digestive system. The main goal is to find the best d…
Matched conditions: NEUROENDOCRINE NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Scientists test new 'Tumor Glow' scan for Hard-to-Spot cancers
Knowledge-focused OngoingThis early-stage study is testing a new imaging agent called 68Ga-FAPI-46 to see where it goes in the body of patients with many different types of cancer. The goal is to understand if this tracer can help doctors better see and understand tumors by highlighting specific cells ar…
Matched conditions: NEUROENDOCRINE NEOPLASM
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC